Detail akcie Kalbe Farma online

Business Summary: PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Kalbe Farma Tbk PT revenues increased 5% to RP30.449T. Net income decreased 18% to RP2.767T. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by R&D - Balancin increase from RP18.18B to RP278.07B (expense), Travelling, conferences and conventions increase from RP59.61B to RP312.06B (expense).